Inogen Announces Participation in 39th Annual William Blair Growth Stock Conference

GOLETA, Calif.–(BUSINESS WIRE)–Inogen,
Inc. (NASDAQ: INGN),
a medical technology company offering innovative respiratory products
for use in the homecare setting, today announced that the Company’s
management will be participating in the 39^th Annual William
Blair Growth Stock Conference in Chicago.

Inogen’s President and CEO, Scott Wilkinson and CFO, Alison Bauerlein
are scheduled to present on Thursday, June 6, 2019 at 11:20 a.m. CT at
the 39^th Annual William Blair Growth Stock Conference.
Interested parties can access the live audio webcast from the Events
section of the Investor Relations page on the Inogen website at www.inogen.com.
A webcast replay will be available approximately one hour after the
conclusion of the live presentation and will remain available for 90
days.

Inogen has used, and intends to continue to use, its Investor Relations
website, http://investor.inogen.com/,
as a means of disclosing material non-public information and for
complying with its disclosure obligations under Regulation FD. For more
information, visit http://investor.inogen.com/.

About Inogen

Inogen is innovation in oxygen therapy. We are a medical technology
company that develops, manufactures and markets innovative oxygen
concentrators used to deliver supplemental long-term oxygen therapy to
patients suffering from chronic respiratory conditions.

For more information, please visit www.inogen.com.

Contacts

Investor Relations Contact:
Matt Bacso, CFA
mbacso@inogen.net

Media Contact:
Byron Myers
805-562-0503